WuXi PharmaTech acquires genomics company NextCODE Health for $65mm
Executive Summary
WuXi PharmaTech Inc. acquired NextCODE Health LLC (genomics analysis and bioinformatics) for $65mm in cash, more than four times the $15mm invested by NextCODE's investors Polaris Partners and Arch Venture Partners. NextCODE will be merged with WuXi's Genome Center to create the new company WuXi NextCODE Genomics, which will be based in Shanghai.
Deal Industry
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Services
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Acquisition of Private Biotech
- Full Acquisition
- Payment Includes Cash
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice